PT Phapros, Tbk (PEHA.JK)

IDR 278.0

(1.46%)

EBITDA Summary of PT Phapros, Tbk

PT Phapros, Tbk's latest annual EBITDA in 2023 was 120.77 Billion IDR , up 0.72% from previous year.
PT Phapros, Tbk's latest quarterly EBITDA in 2024 Q2 was -1.29 Billion IDR , up 81.83% from previous quarter.
PT Phapros, Tbk reported an annual EBITDA of 154.83 Billion IDR in 2022, up 5.3% from previous year.
PT Phapros, Tbk reported an annual EBITDA of 148.32 Billion IDR in 2021, down -36.82% from previous year.
PT Phapros, Tbk reported a quarterly EBITDA of 2.96 Billion IDR for 2024 Q3, up 329.56% from previous quarter.
PT Phapros, Tbk reported a quarterly EBITDA of -15.54 Billion IDR for 2024 Q1, down -112.9% from previous quarter.

Annual EBITDA Chart of PT Phapros, Tbk (2023 - 2011)

Historical Annual EBITDA of PT Phapros, Tbk (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	120.77 Billion IDR	0.72%
2022	154.83 Billion IDR	5.3%
2021	148.32 Billion IDR	-36.82%
2020	210.93 Billion IDR	-13.44%
2019	234.33 Billion IDR	-9.76%
2018	248.04 Billion IDR	15.36%
2017	206.6 Billion IDR	33.07%
2016	157.36 Billion IDR	43.78%
2015	115.36 Billion IDR	25.5%
2014	88.25 Billion IDR	17.53%
2013	68.81 Billion IDR	-31.62%
2012	100.8 Billion IDR	1.99%
2011	96.24 Billion IDR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-1.29 Billion IDR	81.83%
2024 Q3	2.96 Billion IDR	329.56%
2024 Q1	-15.54 Billion IDR	-112.9%
2023 Q3	-7.41 Billion IDR	-129.88%
2023 Q2	24.81 Billion IDR	8.71%
2023 Q1	22.82 Billion IDR	-38.85%
2023 Q4	54.63 Billion IDR	836.79%
2023 FY	- IDR	0.72%
2022 FY	- IDR	5.3%
2022 Q3	27.53 Billion IDR	-1.05%
2022 Q2	27.83 Billion IDR	26.39%
2022 Q1	22.02 Billion IDR	-5.92%
2022 Q4	37.32 Billion IDR	35.55%
2021 Q1	36.5 Billion IDR	8.79%
2021 FY	- IDR	-36.82%
2021 Q4	23.4 Billion IDR	0.11%
2021 Q3	23.38 Billion IDR	-10.76%
2021 Q2	26.2 Billion IDR	-28.22%
2020 Q4	33.55 Billion IDR	143.37%
2020 FY	- IDR	-13.44%
2020 Q1	36.89 Billion IDR	-46.75%
2020 Q2	36.4 Billion IDR	-1.33%
2020 Q3	13.78 Billion IDR	-62.13%
2019 Q3	27.19 Billion IDR	-64.55%
2019 Q4	69.29 Billion IDR	154.8%
2019 FY	- IDR	-9.76%
2019 Q2	76.71 Billion IDR	194.99%
2019 Q1	26 Billion IDR	-61.73%
2018 Q4	67.95 Billion IDR	-1.03%
2018 Q1	22.26 Billion IDR	-73.67%
2018 Q2	61.87 Billion IDR	177.83%
2018 FY	- IDR	15.36%
2018 Q3	68.66 Billion IDR	10.98%
2017 Q4	84.57 Billion IDR	0.0%
2017 FY	- IDR	33.07%
2016 FY	- IDR	43.78%
2015 FY	- IDR	25.5%
2014 FY	- IDR	17.53%
2013 FY	- IDR	-31.62%
2012 FY	- IDR	1.99%
2011 FY	- IDR	0.0%

Peer EBITDA Comparison of PT Phapros, Tbk

Name	EBITDA	EBITDA Difference
PT Darya-Varia Laboratoria Tbk	255.91 Billion IDR	52.807%
PT Merck Tbk	239.49 Billion IDR	49.571%
PT Pyridam Farma Tbk	60.69 Billion IDR	-98.978%
PT Industri Jamu dan Farmasi Sido Muncul Tbk	1323.93 Billion IDR	90.878%
PT Tempo Scan Pacific Tbk	1997.6 Billion IDR	93.954%